Merck & Co Inc (MRK)
131.73
+3.07
(+2.39%)
USD |
NYSE |
May 15, 16:00
132.09
+0.36
(+0.27%)
After-Hours: 20:00
Merck Market Cap: 333.65B for May 15, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 15, 2024 | 333.65B |
| May 14, 2024 | 325.87B |
| May 13, 2024 | 327.47B |
| May 10, 2024 | 329.42B |
| May 09, 2024 | 329.85B |
| May 08, 2024 | 328.13B |
| May 07, 2024 | 330.23B |
| May 06, 2024 | 323.11B |
| May 03, 2024 | 322.96B |
| May 02, 2024 | 324.86B |
| May 01, 2024 | 326.23B |
| April 30, 2024 | 327.29B |
| April 29, 2024 | 329.60B |
| April 26, 2024 | 332.33B |
| April 25, 2024 | 331.12B |
| April 24, 2024 | 321.69B |
| April 23, 2024 | 321.39B |
| April 22, 2024 | 321.54B |
| April 19, 2024 | 318.60B |
| April 18, 2024 | 317.21B |
| April 17, 2024 | 317.57B |
| April 16, 2024 | 316.78B |
| April 15, 2024 | 319.64B |
| April 12, 2024 | 318.50B |
| April 11, 2024 | 319.54B |
| Date | Value |
|---|---|
| April 10, 2024 | 321.06B |
| April 09, 2024 | 320.96B |
| April 08, 2024 | 320.58B |
| April 05, 2024 | 324.20B |
| April 04, 2024 | 323.37B |
| April 03, 2024 | 329.04B |
| April 02, 2024 | 330.18B |
| April 01, 2024 | 331.80B |
| March 28, 2024 | 334.27B |
| March 27, 2024 | 333.76B |
| March 26, 2024 | 317.98B |
| March 25, 2024 | 317.45B |
| March 22, 2024 | 313.75B |
| March 21, 2024 | 313.17B |
| March 20, 2024 | 313.75B |
| March 19, 2024 | 309.57B |
| March 18, 2024 | 307.64B |
| March 15, 2024 | 307.85B |
| March 14, 2024 | 305.29B |
| March 13, 2024 | 309.47B |
| March 12, 2024 | 310.73B |
| March 11, 2024 | 311.01B |
| March 08, 2024 | 312.86B |
| March 07, 2024 | 314.10B |
| March 06, 2024 | 313.50B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
160.34B
Minimum
Mar 23 2020
334.27B
Maximum
Mar 28 2024
227.18B
Average
207.62B
Median
Jun 21 2019
Market Cap Benchmarks
| Amgen Inc | 171.14B |
| Johnson & Johnson | 367.43B |
| Eli Lilly and Co | 747.99B |
| Pfizer Inc | 163.31B |
| Moderna Inc | 49.46B |
Market Cap Related Metrics
| PE Ratio | 146.37 |
| PS Ratio | 5.455 |
| Price to Book Value | 8.266 |
| Price to Free Cash Flow | 30.34 |
| Price | 131.73 |
| Earnings Yield | 0.68% |
| Operating PE Ratio | 68.25 |
| Normalized PE Ratio | 110.01 |